Profile_bird

Hey there! PatentDocs is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What are you doing? Join today to start receiving PatentDocs's tweets.

Already using Twitter
from your phone? Click here.

PatentDocs

  1. Yesterday, Dr. Tafas filed a reply to the GSK/USPTO joint motion to dismiss GSK v. Kappos, seeking resolution of remaining issues.
  2. The USPTO is set to announce the rescission of the "Controversial Patent Regulations Package Proposed by Previous Administration."
  3. The U.S. Patent and Trademark Office introduced a new web interface today.
  4. The USPTO has announced that Chicago-based Foley & Lardner attorney Sharon Barner has been appointed USPTO Deputy Director.
  5. Oral argument in Bilski v. Kappos has been scheduled for Monday, November 9, 2009.
  6. Oral argument in Wyeth v. Kappos (appeal regarding construction of ยง 154(b)(2)(A)) has been scheduled for Wednesday, October 7, 2009.
  7. The Federal Circuit has granted Ariad's petition for rehearing en banc in Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.
  8. The AIPLA is reporting that the U.S. Senate has confirmed David Kappos as Director of the U.S. Patent and Trademark Office.
  9. Hal Wegner is reporting that the DOJ is seeking to defer the Tafas v. Doll en banc hearing until the new Director can review the case.
  10. The CAFC has granted GSK's petition for rehearing en banc in Tafas v. Dudas.
  11. For a report on the White House follow-on biologics letter, please visit: http://www.patentdocs.org/
  12. Reuters reports that the White House has sent a letter to Rep. Waxman recommending a 7-year data exclusivity period for follow-on biologics.
  13. Senator Patrick Leahy has released a statement announcing that President Obama intends to nominate David Kappos as USPTO Director.
  14. The USPTO has announced the release of a beta version of its new website: http://beta.uspto.gov/